Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 2 Interventional

Intra-Articular Allocetra in Patients With Primary Knee Osteoarthritis

ClinicalTrials.gov ID: NCT07580716

Public ClinicalTrials.gov record NCT07580716. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 8:57 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase IIb, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Intra-Articular Allocetra in Patients With Primary Knee Osteoarthritis

Study identification

NCT ID
NCT07580716
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Enlivex Therapeutics Ltd.
Industry
Enrollment
270 participants

Conditions and interventions

Interventions

  • Allocetra Drug
  • Placebo Other

Drug · Other

Eligibility (public fields only)

Age range
64 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2026
Primary completion
Jan 31, 2027
Completion
Mar 31, 2028
Last update posted
May 19, 2026

2026 – 2028

United States locations

U.S. sites
4
U.S. states
3
U.S. cities
4
Facility City State ZIP Site status
Future Medical Research Longwood Florida 32750 Recruiting
South Florida Research Phase I-IV Miami Florida 33166 Not yet recruiting
DelRicht Research @ Touro Medical Center New Orleans Louisiana 70115 Recruiting
Oakland Medical Research Troy Michigan 48085 Not yet recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 13 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07580716, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 19, 2026 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07580716 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →